| Source: |
| Type: |
| PFKFB4 (6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 4) — Bifunctional metabolic enzyme that regulates intracellular fructose-2,6-bisphosphate (F2,6BP), a potent allosteric activator of phosphofructokinase-1 (PFK1). PFKFB4 helps coordinate glycolytic flux, pentose-phosphate pathway activity, redox balance, and metabolic adaptation to cellular stress. Typical modulation in cancer: Frequently ↑ and generally unfavorable. Elevated PFKFB4 supports tumor-cell survival, metabolic flexibility, NADPH/redox homeostasis, proliferation, hypoxia adaptation, and resistance to oxidative and nutrient stress. PFKFB4 inhibition can impair tumor growth in several experimental cancer models. Typical mechanistic relationship: PFKFB4 activity → F2,6BP regulation → PFK1/glycolysis modulation and redistribution of glucose-derived carbon between glycolysis and the pentose-phosphate pathway → NADPH and biosynthetic support ↑ → tumor-cell survival and proliferation ↑. Hypoxia relevance: PFKFB4 is often induced in hypoxic or metabolically stressed tumor cells and can contribute to HIF-associated metabolic adaptation. |
| 9242- | ISO, IH, | Isorhamnetin Induces Melanoma Cell Apoptosis via the PI3K/Akt and NF- κ B Pathways |
| - | vitro+vivo, | Melanoma, | B16-BL6 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:0 prod#:% Target#:1931 State#:% Dir#:0
wNotes=0 sortOrder:rid,rpid